Want to join the conversation?
$BCR's consolidated net sales of urology products in 2015 rose 1% (4% on constant currency basis) from last year. This rise was primarily due to growth in sales of basic drainage products and Targeted Temperature Management products. U.S. sales of urology products rose by 4%, while International sales slid by 5% (up 3% on constant currency).
Apple ($AAPL) reported decline in sales and profits from comparable quarter last year, attributing the decline to announcement of iPhone 7/7s. Sales and profit are being guided higher for next quarter. Apple is a solid company and will continue to dominate tech and consumer electronics segment for a while. Personally, looks like there is little downside in this investment.
Waiting with fingers crossed for $AAPL’s fourth quarter earnings.
Looking ahead to $AAPL earnings release later in the afternoon today? Gene Munster, analyst from Piper Jaffrey and the most respected authority for Apple, had this to say - "The second and slightly larger group of investors believe the tail of the iPhone 7 is irrelevant, and is betting that the iPhone 10th Anniversary will yield a jump in growth from flat to up ~15%."